title: Ectopic pregnancy.
abstract: Ectopic pregnancy is a implantation occurring elsewhere than in the cavity of the uterus, whereas ninety-nine percent of extrauterine pregnancies occur in the fallopian tube. The incidence of extrauterine pregnancy has increased from 0.5% thirty years ago, to a present day 1-2%. The most frequent cause of tubal pregnancy is previous salpingitis. Mortality rates for tubal pregnancies used to be approximately 1.7% in the 1970s but dropped to 0.3% in 1980s.
  
  
  METHODS
  Using transvaginal ultrasound it is possible to obtain positive evidence of an ectopic pregnancy at a very early stage. In cases of hCG titers>2,000 IU/l, intrauterine pregnancy can be diagnosed with certainty. The most important differential diagnosis of ectopic pregnancy is early intrauterine pregnancy.
  Regardless of the therapeutic strategy selected by the physician, informing the patient is a major aspect of the management of ectopic pregnancy. If surgery is considered appropriate, the patient must be informed about the nature, side effects and complications of the procedure. However, it should be remembered that in some cases, the actual chances of cure first become apparent at surgery. In asymptomatic patients with a serum hCG titer <1,000 IU/l that is falling, it is appropriate to wait and watch. In clinically stable patients with an unruptured tubal pregnancy and steady hCG levels, systemic treatment with methotrexate might also be considered. In unruptured tubal pregnancy with a hCG titer between 1,000 and 2,500, a further therapeutic alternative is intratubal injection of prostaglandins, hyperosmolar glucose of NaCl. Generally speaking, the currently widespread laparoscopic surgical treatment of the fallopian tube hardly influences the risk of recurrence. If the gestational mass is larger, the serum hCG titer higher than the approximate limit of 2,500 mU/ml and/or the tube already ruptured, surgery is usually required.
  
  
  CONCLUSIONS
  The most effective prevention is to avoid tubal inflammation or, in cases of preexisting inflammation, to administer effective therapy.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Vienna, Austria. Rainer.Lehner@akh-wien.ac.at
authors.forename: R
authors.initials: R
authors.lastname: Lehner
authors.forename: E
authors.initials: E
authors.lastname: Kucera
authors.forename: S
authors.initials: S
authors.lastname: Jirecek
authors.forename: C
authors.initials: C
authors.lastname: Egarter
authors.forename: P
authors.initials: P
authors.lastname: Husslein
mesh_terms: D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D006801:Humans; D007258:Informed Consent; D010535:Laparoscopy; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*
chemical_list: D006063:Chorionic Gonadotropin